EMEA-000183-PIP02-12-M02

Key facts

Invented name
Eliquis
Active substance
Apixaban
Therapeutic area
Cardiovascular diseases
Decision number
P/0153/2018
PIP number
EMEA-000183-PIP02-12-M02
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral liquid dosage form
  • Age-appropriate dosage form, other
Condition(s) / indication(s)
Treatment of venous thromboembolism
Route(s) of administration
Oral use
Contact for public enquiries
Bristol-Myers Squibb / Pfizer EEIG

E-mail: medical.information@bms.com
Tel. +44 (0)1895 523740

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating